Proteins & Vaccines | Track record

Since 1992 SynCo’s facilities have been a licensed manufacturing site for drug substance and aseptically prepared small volume parenterals (drug product). SynCo’s GMP license covers both clinical and commercial supply of wide variety of biopharmaceutical products.

SynCo aims for a long term partnership and has brought several protein & vaccine projects over the past years, from early stage development through the clinical phases into commercial launch and production.

Some of the production organisms that SynCo has experience with are:

  • Escherichia coli
  • Pseudomonas fluorescens
  • Haemophilus influenzae type B
  • Corynebacterium diphtheriae
  • Neisseria meningitidis (group A, C)
  • Bordetella pertussis
  • Pichia pastoris
  • Saccharomyces cerevisiae